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UNIT A27.2Masses of the Elbow and Forearm
MRI is valuable for mass localization and evaluation because of its multiplanar capabili-
ties and soft-tissue detail. While in many instances the imaging findings may not be
specific, MRI can be very sensitive. The technique used plays a vital role in the pathway
to the differential diagnosis and staging of a mass lesion by defining the precise anatomic
involvement, relationships, and intrinsic characteristics.
BASIC
PROTOCOL
IMAGING OF THE ELBOW
As in routine imaging of the elbow, a dedicated extremity coil is preferred. The sequences
should include T1- and T2-weighted sequences for tissue characterization. Fat-suppression
images should also be included to increase sensitivity as well as for possible fat tissue
characterization. Images should be obtained in at least two and preferably all three planes
for anatomic demonstration and involvement. The transverse plane should always be
included. Additional long axis planes would include sagittal for antero-posterior masses
and coronal for medio-lateral masses; if possible, both are generally helpful. T1-weighted
images are vital in tumor evaluation because of the anatomic soft tissue and cortical detail
and for demonstration of fat or hemorrhage components. It is this anatomic and tissue
definition that may aid the diagnosis or in determining the diagnostic category, in addition
to providing a map for possible surgical management. A fat-saturated T2-weighted or
STIR (short-tau inversion recovery) sequence is also recommended. STIR sequences
should be substituted for the fat-saturated sequences to achieve more homogeneous fat
suppression when field uniformity may be poor. With lower-field scanners, where fat
saturation sequences may not be available, STIR sequences generally still provide good
fat suppression. The fat-suppressed longer TE (T2-weighted) and STIR sequences are
highly sensitive to marrow edema. A T2-weighted sequence without fat suppression in
one of the three planes is helpful to assist in demonstrating true high-signal fluid in a
cystic or necrotic lesion (Kneeland, 1997; Steinbach et al., 1997a).
Table A27.2.1 lists the hardware necessary to perform the procedure, along with appro-
priate parameters. The available gradient strength will depend on the scanner, and the
echo times given in other tables below may be varied accordingly (the smaller the gradient
strength, the longer the echo time for a particular scan).
In summary, our standard protocol consists of coronal and sagittal T1-weighted and
fat-saturated T2-weighted (or STIR) images, transverse proton density- and T2-weighted
images, as detailed below. Total exam time is ∼25 min.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
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Table A27.2.1 Equipment Parameters for MRI of the Elbow
Coil type Phased array extremity coil
Gradient coil strength 25 mT/m (or whatever the system permits)
Cardiac gating No
Peripheral gating No
Respiratory gating No
Oxygen No
Motion cushions Useful
Use of contrast agent No (but used in Alternate Protocol)
A27.2.1
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Set up patient and equipment
1. Interview (screen) the patient to ensure that there are no contraindications for the
MRI exam such as cardiac pacemakers, cerebral aneurysm clips, biostimulators, and
metallic bodies within the orbit, or other electronic devices sensitive to magnetic
fields. Question the patient regarding medical conditions that may require emergency
care or equipment, in addition to conditions that would inhibit the patient from being
able to complete the exam.
Generally, standard screening forms (see APPENDIX 1) are used for all patients scanned in
a magnetic resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(2001) for discussion of what implants may be safely scanned using magnetic resonance.
Orthopedic hardware is not a contraindication. However, ferromagnetic and even nonfer-
romagnetic material in this hardware will produce artifacts that may degrade the exam.
Adjustments to the technique may be made as discussed below.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
forms.
3. Have the patient remove all jewelry and clothing items or accessories that may contain
metal and change into a gown to eliminate the presence of any metal that might be
found in clothing. Remove pants due to the positioning of the arm adjacent to the hip.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earplugs or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. Establish a method of communication with the patient using either an intercom or
signaling device.
c. In order to obtain good results, the patient should not talk, and should avoid or
minimize other movement, during each scan—i.e., as long as the banging sounds
continue. Between scans, talking is allowed in most cases, but should be avoided
when comparative positional studies are being performed; the patient will be
informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Tape a surface marker (a cod liver oil or vitamin E pill) over the symptomatic site or
palpable abnormality. Do not compress a superficial mass.
The cod liver oil pill shows up better on STIR sequences.
7. Have the patient lie supine with the forearm in supination at his or her side. Place the
elbow in full extension into the RF coil with the antecubital fossa in the center of the
coil; the patient’s arm (not necessarily the body) should be straight and parallel to the
scanning table; the arm will be parallel to the main field for a cylindrical magnet and
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perpendicular to the main field for a vertical-field magnet. Place sandbags on the arm
and lateral to the arm in order to prevent potential motion of the arm.
A small-angle sponge may be placed under the hand/forearm for very slight flexion of the
elbow joint, which may allow for more comfort and therefore reduce potential motion.
8. Advance the scan table until the centering light is at the center of the RF coil. Evaluate
for right/left and anterior/posterior offsets and use these values for localizer setup.
Advance the patient to the isocenter of the magnet.
Table A27.2.2 Primary Clinical Imaging Parameters for Sequence 1 (Localizer)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Three planes (if unavailable use
transverse plane)
Central slice or volume center Center of mass
Echo time (TE) 5 msec
Repeat time (TR) 15 msec
Flip angle (FA) 40°
Fields of view (FOVx, FOVy) 200 mm, 200 mm (varies with the
mass)
Resolution (∆x, ∆y) 0.78 mm, 1.56 mm
Number of data points collected (Nx, Ny) 256, 128
Slice thickness (∆z) 5 mm
Number of slices 9 (3 per plane)
Slice gap 1.5 mm
Number of acquisitions (Nacq) 1
Scan time 23 sec
A B
Figure A27.2.1 (A) Transverse scout for coronal images. Oblique coronal images are obtained parallel to a line connecting
the humeral condyles anteriorly. (B) Sagittal scout for coronal images. Oblique coronal images are obtained parallel to a line
along the long axis of the upper arm and forearm in the sagittal plane.
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Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then returned to the same position as before without
jeopardizing the positioning of one scan relative to another.
9. If the patient is unable to lie still, provide an appropriate sedative.
Sequence 1: Localizer
10. Run the localizer (scout) to ensure the correct location of the elbow in three
orientations using the imaging parameters in Table A27.2.2.
Table A27.2.3 Primary Clinical Imaging Parameters for Sequence 2 (Coronal
T1-Weighted)
Patient position Supine
Scan type Fast spin echo (FSE)
Imaging plane (orientation) Coronal oblique
Central slice or volume center Center of mass
Echo time (TE) 17 msec
Echo train length (ETL) 3
Repeat time (TR) 493 msec
Flip angle (FA) 180°a
Fields of view (FOVx, FOVy) 110 mm, 110 mm
Resolution (∆x, ∆y) 0.43 mm, 0.54 mm
Number of data points collected (Nx, Ny) 256, 204b
Slice thickness (∆z) 3.5 mm
Number of slices 16
Slice gap 0.4 mm
Number of excitations (NEX) 2c
Number of acquisitions (Nacq) 2
Scan time 3 min, 24 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence is 90°.
bAn additional 50% phase oversampling is applied.
cThe number of concatenation is set to be 2. This means that only half of the total slices will be excited
during a given repeat time.
Table A27.2.4 Primary Clinical Imaging Parameters for Sequence 3 (Coronal STIR)
Patient position Supine
Scan type Inversion recovery, fast spin echo
Imaging plane (orientation) Coronal oblique
Central slice or volume center Center of mass
Echo time (TE) 30 msec
Echo train length (ETL) 7
Repeat time (TR) 4100 msec
Inversion time (TI) 140 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 110 mm, 110 mm
Resolution (∆x, ∆y) 0.43 mm, 0.54 mm
Number of data points collected (Nx, Ny) 256, 205a
Slice thickness (∆z) 3.5 mm
Number of slices 16
Slice gap 0.4 mm
Number of acquisitions (Nacq) 1
Scan time 3 min, 45 sec
aAn additional 80% phase oversampling is applied.
Supplement 10 Current Protocols in Magnetic Resonance Imaging
A27.2.4
Masses of the
Elbow and
Forearm
A B
Figure A27.2.2 (A) Coronal scout for setting up transverse images. Transverse images should be obtained tangentially to
the humeral condyle surface. Images may need to extend beyond routine parameters to include the entire mass lesion. (B)
Sagittal scout for planning transverse images, which should be obtained orthogonally to the long axis of the elbow in the
sagittal plane.
Table A27.2.5 Primary Clinical Imaging Parameters Sequence 4 (Transverse PD-
and T2-Weighted)
Patient Position Supine
Scan type Fast spin echo, dual echo (PD- and
T2-weighted)
Imaging plane (orientation) Transverse
Central slice or volume center Center of mass
Echo time (TE) 15 msec and 92 msec
Echo train length (ETL) 5
Repeat time (TR) 3000 msec
Flip angle (FA) 150°a
Fields of view (FOVx, FOVy) 110 mm, 110 mm
Resolution (∆x, ∆y) 0.43 mm, 0.43 mm
Number of data points collected (Nx, Ny) 256, 256b
Slice thickness (∆z) 3 mm
Number of slices 16
Slice gap 0.3 mm
Number of acquisitions (Nacq) 1
Scan time ∼5 min
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
bAn additional 80% phase oversampling is applied.
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Figure A27.2.3 (A) Transverse scout for setting up sagittal images. Sagittal images are obtained perpendicular to coronal
plane. The first and last images should include the epicondyle tips. (B) Coronal scout for planning sagittal images. Sagittal
images should be parallel to the long axis of the elbow in the coronal plane of the scout image.
Table A27.2.6 Primary Clinical Imaging Parameters for Sequence 5 (Sagittal
T1-Weighted)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Center of mass
Echo time (TE) 17 msec
Echo train length (ETL) 3
Repeat time (TR) 493 msec
Flip angle (FA) 180°a
Fields of view (FOVx, FOVy) 110 mm, 110 mm
Resolution (∆x, ∆y) 0.43 mm, 0.54 mm
Number of data points collected (Nx, Ny) 256, 204b
Slice thickness (∆z) 3.5 mm
Number of slices 16
Slice gap 0.4 mm
Number of excitations (NEX) 2c
Number of acquisitions (Nacq) 2
Scan time 3 min, 24 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
bAn additional 50% phase oversampling is applied.
cThe number of concatenation is set to be 2. This means that only half of the total slices will be excited
during a given repeat time.
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Sequence 2: Coronal T1-weighted
11. Use the localizer images to center at the joint line. Prescribe off transverse or sagittal
scout images, in order to obtain coronal images (see Fig. A27.2.1). Run sequence 2
according to the parameters in Table A27.2.3.
Refer to the sample images in Figures A27.2.1A and B.
Sequence 3: Coronal STIR
12. Run sequence 3 according to the parameters in Table A27.2.4.
Sequence 4: Transverse proton density weighted and T2-weighted
13. Prescribe off coronal or sagittal scout images in order to obtain transverse images
(see Fig. A27.2.2).
14. Run sequence 4 according to the parameters in Table A27.2.5.
Sequence 5: Sagittal T1-weighted
15. Prescribe off transverse or coronal scout images in order to obtain sagittal images
(see Fig. A27.2.3).
16. Run sequence 5 according to the parameters in Table A27.2.6.
Sequence 6: Sagittal fat-suppressed T2-weighted
17. Run sequence 6 according to the parameters in Table A27.2.7.
Also, an STIR sequence may be substituted for the sagittal fat saturated T2-weighted
sequence. An STIR sequence may be an alternative fat-suppression sequence, e.g., for
mid/low-field scanners for which frequency-selective fat-saturation or fat suppression is
not available, or for high-field scanners where field homogeneity is suspect and fat
saturation is nonuniform.
Table A27.2.7 Primary Clinical Imaging Parameters for Sequence 6
(Fat-Suppressed T2-Weighted)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Center of mass
Echo time (TE) 44 msec
Echo train length (ETL) 5
Repeat time (TR) 3000 msec
Flip angle 180°a
Fields of view (FOVx, FOVy) 110 mm, 110 mm
Resolution (∆x, ∆y) 0.43 mm, 0.43 mm
Number of data points collected (Nx, Ny) 256, 256b
Slice thickness (∆z) 3.5 mm
Number of slices 20
Slice gap 0.4 mm
Number of acquisitions (Nacq) 1
Fat suppression Yes
Scan time 4 min, 53 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
bAn additional 80% phase oversampling is applied.
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ALTERNATE
PROTOCOL
ADDITIONAL FAT-SUPPRESSED SEQUENCES AND INTRAVENOUS
POST-CONTRAST SEQUENCES
Post-contrast images are optional and in many cases do not contribute to the diagnosis.
However, intravenous gadolinium contrast agent may help to differentiate cystic or
necrotic lesions from solid masses by defining a nodular or peripheral enhancing compo-
nent in a cystic lesion versus more diffuse enhancement in a solid mass. In some cases,
conversely, initial imaging without contrast agents may reveal the diagnosis and exclude
the need for post-contrast imaging. Contrast agents may also be helpful in defining extent
of a mass, but at times may be misleading for mass margins, as microscopic tumor
involvement may extent beyond the macroscopic enhancing region of a mass. In general,
the authors do not use contrast agents for evaluation of a mass lesion.
Standard, single-dose gadolinium contrast agent may be administered as an intravenous
injection. Post-contrast T1-weighted images (with fat suppression if available) can then
be performed in transverse and coronal and/or sagittal planes. Pre-contrast T1-weighted
images should also be performed for comparison.
If a gadolinium i.v. contrast agent is to be used, the standard protocol is as follows: first,
pre-contrast coronal or sagittal T1-weighted images (depending on orientation of mass),
and transverse proton-density- and T2-weighted images, then, post-contrast coronal,
sagittal, and transverse T1-weighted images with fat suppression. The total scan time with
contrast sequences is 30 to 45 min, including injection time.
Materials
Normal saline (0.9% NaCl), sterile
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, or Prohance)
21- to 23-G butterfly needle
Set up patient and equipment
1. Set up patient as in the Basic Protocol, steps 1 to 6.
2. Access a vein in the forearm not being imaged and, using a 21- to 23-G butterfly
needle, establish an intravenous line through which the contrast agent can be injected.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet, so
that there is no intervening motion between the scans run before contrast agent injection
and those run after injection.
3. Finish setting up the patient by performing steps 7 to 9 of the Basic Protocol.
4. Run sequences 1, 2 (or 5), and 4 in the Basic Protocol.
5. Without removing the patient from the magnet, inject the contrast agent and flush the
intravenous line with 10 ml saline solution.
A standard single dose of 0.1 mmol/kg of contrast agent is usually given.
Sequence 7: Transverse fat-suppressed T1-weighted
6. Run sequence 7 according to the imaging parameters in Table A27.2.8.
Sequence 8: Coronal fat-suppressed T1-weighted
7. Run sequence 8 according to the imaging parameters in Table A27.2.9.
Sequence 9: Sagittal fat-suppressed T1-weighted
8. Run sequence 9 according to the imaging parameters in Table A27.2.9.
Supplement 10 Current Protocols in Magnetic Resonance Imaging
A27.2.8
Masses of the
Elbow and
Forearm
Table A27.2.9 Primary Clinical Imaging Parameters for Sequence 8 (Coronal
and/or Sagittal Fat-Suppressed T1-Weighted)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Coronal or sagittal
Central slice or volume center Center of joint
Echo time (TE) 19 msec
Echo train length (ETL) 3
Repeat time (TR) 699 msec
Flip angle 180°a
Fields of view (FOVx, FOVy) 110 mm, 110 mm
Resolution (∆x, ∆y) 0.43 mm, 0.43 mm
Number of data points collected (Nx, Ny) 256, 256b
Slice thickness (∆z) 3.5 mm
Number of slices 16
Slice gap 0.4 mm
Number of excitations (NEX) 2c
Number of acquisitions (Nacq) 1
Fat suppression Yes
Scan time 4 min, 2 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
bAn additional 50% phase oversampling is applied.
cThe number of concatenation is set to be 2. This means that only half of the total slices will be excited
during a given repeat time.
Table A27.2.8 Primary Clinical Imaging Parameters for Sequence 7 (Transverse
Fat-Suppressed T1-Weighted)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Center of joint
Echo time (TE) 19 msec
Echo train length (ETL) 3
Repeat time (TR) 699 msec
Flip angle (FA) 150°a
Fields of view (FOVx, FOVy) 110 mm, 110 mm
Resolution (∆x, ∆y) 0.43 mm, 0.43 mm
Number of data points collected (Nx, Ny) 256, 256b
Slice thickness (∆z) 3 mm
Number of slices 16
Slice gap 0.3 mm
Number of excitations (NEX) 2c
Number of acquisitions (Nacq) 1
Fat suppression Yes
Scan time 4 min, 2 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
bAn additional 100% phase oversampling is applied.
cThe number of concatenation is set to be 2. This means that only half of the total slices will be excited
during a given repeat time.
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COMMENTARY
Background Information
Musculoskeletal tumors of the elbow are un-
usual. By category, there are benign and malig-
nant soft tissue and osseous masses. More com-
monly, benign masses occur as a result of acute
trauma, chronic overuse, or arthropathy, and may
simulate a tumor or more aggressive process.
These include a retracted mass of torn tendon
tissue, bursal collections, synovial or ganglion
cysts, loose bodies, and scar tissue. Post-traumatic
myositis ossificans presents as an area of soft-tis-
sue swelling and/or hematoma that eventually
undergoes a characteristic ossification pattern and
may mimic a tumor. Synovial disorders (such as
pigmented villonodular synovitis and synovial
chondromatosis), gout, hemophilia, and neuropa-
thic joints frequently present with masses about
the joint. The most commonly occurring benign
soft tissue tumors include lipomas, vascular tu-
mors such as hemangiomas, and benign neural
tumors, all of which often have definitive imaging
characteristics and do not require post-contrast
imaging. Malignant soft tissue tumors of the
elbow are generally sarcomas and include liposar-
coma, malignant fibrous histiocytoma, and
synovial sarcoma. These tumors have nondefini-
tive imaging characteristics, but MR imaging may
be vital in the evaluation of the extent of soft tissue
involvement for tumor staging, as well as post-
operative evaluation.
Benign and malignant osseous masses are
generally better evaluated on plain film and com-
puted tomography for specificity. However, MR
imaging plays an important role in evaluation of
soft tissue structures involved and for extent of
bone/marrow involvement. The majority of bone
tumors (50%) occur in the ulna, with 20% occur-
ring in the radius, 20% in the humerus, and 10%
in the soft tissues. Overall, benign osseous tumors
are more common. Benign tumors that can occur
on the elbow, although unusual, include
osteoblastomas, osteochondromas, chondroblas-
tomas, and enchondromas. Additionally, fibrous
dysplasia, giant cell tumors, aneurismal bone
cysts, and unicameral bone cysts may occur. Sub-
tle MR imaging findings of periostitis, nidus, and
marrow edema may diagnose an unsuspected
osteoid osteoma. The most common malignant
osseous lesion about the elbow is metastasis.
Plasmacytomas and multiple myeloma are the
most common primary bone tumors, but much
more commonly occur in the axial and proximal
appendicular skeleton. Other primary malignant
bone tumors include osteosarcoma, chondrosar-
coma, Ewing’s sarcoma, and primary malignant
lymphoma. MR imaging is most useful in deline-
ating and staging these tumors (Ma, 1999; Stein-
bach et al., 1997a,b).
Critical Parameters and
Troubleshooting
Field of view
Masses may extend beyond the normal fields
of view (FOV) which may require the FOV to be
increased to include all of the abnormality. Alter-
natively, additional imaging of the proximal
humerus or distal forearm may provide the opti-
mal evaluation without the sacrifice of resolution.
In these instances, the elbow joint line should be
included at the edge of the additional sagittal
and/or coronal images to show the extent and
location of the mass relative to the joint line.
Contrast
The need for post-contrast imaging is variable,
as discussed in the Alternate Protocol.
Anticipated Results
The role of MRI in evaluating masses occur-
ring on the elbow is to define the lesion by its
location, intrinsic characteristics, and extent in-
cluding structures involved. This information will
lead the radiologist and the clinician to the diag-
nosis, differential diagnosis, or diagnostic cate-
gory. It will also provide preoperative assessment
or staging of the elbow when needed.
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